• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆酸作为一种新型甾体激素调节机体非特异性能量消耗(综述)。

Bile Acids as a New Type of Steroid Hormones Regulating Nonspecific Energy Expenditure of the Body (Review).

机构信息

Associate Professor, Department of Biochemistry named after G.Ya. Gorodisskaya; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.

Professor, Head of the Department of Biochemistry named after G.Ya. Gorodisskaya Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.

出版信息

Sovrem Tekhnologii Med. 2021;12(5):114-127. doi: 10.17691/stm2020.12.5.13. Epub 2020 Oct 28.

DOI:10.17691/stm2020.12.5.13
PMID:34796012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8596256/
Abstract

The review is devoted to the systematization, classification, and generalization of the results of modern scientific research on the role of bile acids as a new class of steroid hormones. The paper presents the evidence for bile acid participation in the regulation of the body energy metabolism, body weight control, as well as the pathogenesis of obesity, diabetes mellitus, insulin resistance, and cardiovascular diseases. Particular attention is paid to the role of bile acids in the control of nonspecific energy expenditure of the body. The applied aspects of using the novel data about the membrane and intracellular receptors responsible for the development of hormonal regulatory effects of bile acids are analyzed. According to the authors, the modern data on the role of bile acids in the regulation of body functions allow a deeper understanding of the pathogenesis of body weight disorders and associated cardiovascular diseases. The review demonstrates promising directions in the search for specific methods of prevention and correction of these pathological conditions.

摘要

这篇综述致力于将现代科学研究关于胆汁酸作为一类新型甾体激素的作用的结果进行系统化、分类和概括。本文介绍了胆汁酸参与调节机体能量代谢、体重控制以及肥胖症、糖尿病、胰岛素抵抗和心血管疾病发病机制的证据。特别关注胆汁酸在控制机体非特异性能量消耗中的作用。分析了应用有关负责胆汁酸激素调节作用发展的膜和细胞内受体的新数据的方面。作者认为,关于胆汁酸在调节机体功能中的作用的现代数据可以更深入地了解体重紊乱和相关心血管疾病的发病机制。该综述展示了在寻找预防和纠正这些病理状况的具体方法方面的有前景的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/1c982444e0cb/STM-12-5-13-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/7e39a3875861/STM-12-5-13-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/97311be6ab55/STM-12-5-13-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/1c982444e0cb/STM-12-5-13-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/7e39a3875861/STM-12-5-13-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/97311be6ab55/STM-12-5-13-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e7/8596256/1c982444e0cb/STM-12-5-13-f3.jpg

相似文献

1
Bile Acids as a New Type of Steroid Hormones Regulating Nonspecific Energy Expenditure of the Body (Review).胆酸作为一种新型甾体激素调节机体非特异性能量消耗(综述)。
Sovrem Tekhnologii Med. 2021;12(5):114-127. doi: 10.17691/stm2020.12.5.13. Epub 2020 Oct 28.
2
Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease.胆汁酸在调节食物摄入中的作用,及其在代谢性疾病中的失调。
Nutrients. 2021 Mar 28;13(4):1104. doi: 10.3390/nu13041104.
3
Bile acids, obesity, and the metabolic syndrome.胆汁酸、肥胖与代谢综合征
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):573-83. doi: 10.1016/j.bpg.2014.07.004. Epub 2014 Jul 11.
4
Gut microbiome and bile acids in obesity-related diseases.肥胖相关疾病中的肠道微生物组和胆汁酸。
Best Pract Res Clin Endocrinol Metab. 2021 May;35(3):101493. doi: 10.1016/j.beem.2021.101493. Epub 2021 Feb 10.
5
Effects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjects.肥胖胰岛素抵抗患者急性饮食减重对餐后血浆胆汁酸反应的影响。
Clin Nutr. 2017 Dec;36(6):1615-1620. doi: 10.1016/j.clnu.2016.10.006. Epub 2016 Oct 13.
6
TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice.TGR5有助于小鼠垂直袖状胃切除术后的血糖调节改善。
Gut. 2017 Feb;66(2):226-234. doi: 10.1136/gutjnl-2015-309871. Epub 2015 Oct 28.
7
Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes.胆汁酸:2型糖尿病的关键调节因子和新型治疗靶点
J Diabetes Res. 2020 Jul 17;2020:6138438. doi: 10.1155/2020/6138438. eCollection 2020.
8
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?非酒精性脂肪性肝病、肥胖症、胰岛素抵抗和 2 型糖尿病患者的胆汁酸变化:人体研究告诉了我们什么?
Curr Opin Lipidol. 2019 Jun;30(3):244-254. doi: 10.1097/MOL.0000000000000597.
9
Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgery.通过胆总管手术后胆汁酸升高缓解糖尿病Goto-Kakizaki大鼠的2型糖尿病
Metabolism. 2016 Feb;65(2):78-88. doi: 10.1016/j.metabol.2015.09.014. Epub 2015 Sep 26.
10
Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.红参提取物通过激活肠道 TGR5 介导的胆汁酸信号通路改善高脂饮食诱导的肥胖和胰岛素抵抗。
Phytomedicine. 2023 Oct;119:154982. doi: 10.1016/j.phymed.2023.154982. Epub 2023 Jul 22.

引用本文的文献

1
Spaceflight alters host-gut microbiota interactions.太空飞行改变了宿主-肠道微生物群的相互作用。
NPJ Biofilms Microbiomes. 2024 Aug 29;10(1):71. doi: 10.1038/s41522-024-00545-1.
2
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases.胆汁酸稳态失调:揭示其在代谢性疾病中的作用。
Med Rev (2021). 2024 Jun 4;4(4):262-283. doi: 10.1515/mr-2024-0020. eCollection 2024 Aug.
3
Bioinformatic Identification of Hub Genes Related to Menopause-Obesity Paradox in Breast Cancer.乳腺癌中与绝经-肥胖悖论相关的枢纽基因的生物信息学鉴定

本文引用的文献

1
Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors.胆汁酸激活受体:GPBAR1(TGR5)及其他G蛋白偶联受体
Handb Exp Pharmacol. 2019;256:19-49. doi: 10.1007/164_2019_230.
2
Bile Acids in Cholestasis and its Treatment.胆汁淤积症中的胆汁酸及其治疗
Ann Hepatol. 2017 Nov;16 Suppl 1:S53-S57. doi: 10.5604/01.3001.0010.5497.
3
Developments in bile salt based therapies: A critical overview.胆汁盐治疗方法的进展:批判性综述。
Int J Endocrinol Metab. 2023 Nov 6;21(4):e140835. doi: 10.5812/ijem-140835. eCollection 2023 Oct.
4
Bile Acids as Inducers of Protonophore and Ionophore Permeability of Biological and Artificial Membranes.胆汁酸作为生物膜和人工膜质子载体及离子载体通透性的诱导剂
Membranes (Basel). 2023 Apr 28;13(5):472. doi: 10.3390/membranes13050472.
5
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism.计算机预测甾体和三萜类化合物作为潜在的脂代谢调节剂。
Mar Drugs. 2021 Nov 22;19(11):650. doi: 10.3390/md19110650.
Biochem Pharmacol. 2019 Mar;161:1-13. doi: 10.1016/j.bcp.2018.12.018. Epub 2018 Dec 22.
4
Constitutive androstane receptor 1 is constitutively bound to chromatin and 'primed' for transactivation in hepatocytes.组成型雄烷受体 1 与染色质结合,在肝细胞中为转录激活 '准备'。
Mol Pharmacol. 2019 Jan;95(1):97-105. doi: 10.1124/mol.118.113555. Epub 2018 Oct 25.
5
Activation of estrogen receptor alpha induces beiging of adipocytes.雌激素受体α的激活诱导脂肪细胞的米色化。
Mol Metab. 2018 Dec;18:51-59. doi: 10.1016/j.molmet.2018.09.002. Epub 2018 Sep 15.
6
FXR modulators for enterohepatic and metabolic diseases.法尼醇 X 受体调节剂在肝胆和代谢疾病中的应用。
Expert Opin Ther Pat. 2018 Nov;28(11):765-782. doi: 10.1080/13543776.2018.1527906. Epub 2018 Oct 8.
7
Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes.肠道胆汁酸螯合通过刺激 2 型糖尿病肝 miR-182-5p 改善血糖控制。
Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1;315(5):G810-G823. doi: 10.1152/ajpgi.00238.2018. Epub 2018 Aug 30.
8
Metabolites as regulators of insulin sensitivity and metabolism.代谢物作为胰岛素敏感性和代谢的调节剂。
Nat Rev Mol Cell Biol. 2018 Oct;19(10):654-672. doi: 10.1038/s41580-018-0044-8.
9
Update on FXR Biology: Promising Therapeutic Target?FXR 生物学研究进展:有前途的治疗靶点?
Int J Mol Sci. 2018 Jul 16;19(7):2069. doi: 10.3390/ijms19072069.
10
Bile acids and FXR in functional gastrointestinal disorders.胆汁酸和法尼醇 X 受体在功能性胃肠病中的作用。
Dig Liver Dis. 2018 Aug;50(8):795-803. doi: 10.1016/j.dld.2018.05.016. Epub 2018 May 30.